Trial intelligence / Profile preview

Prophylactic Antibiotics After Surgical Evacuation of Miscarriage

NCT05040334Phase 4Unknown

Sponsor
Cairo University
Start
Jan 2021
Primary completion
Apr 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of doxycycline, metronidazole in pelvic inflammatory disease (PID), puerperal sepsis, sponsored by Cairo University. Status: unknown.

02

Drugs

doxycyclinemetronidazole
03

Conditions

pelvic inflammatory disease (PID)puerperal sepsis

Beyond the preview

Go deeper on NCT05040334.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05040334.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call